- Home
- FATE vs STHO Comparison
FATE vs STHO Comparison
Compare FATE & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FATE
- STHO
- Stock Information
- Founded
- FATE 2007
- STHO N/A
- Country
- FATE United States
- STHO United States
- Employees
- FATE N/A
- STHO N/A
- Industry
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- STHO Real Estate
- Sector
- FATE Health Care
- STHO Real Estate
- Exchange
- FATE Nasdaq
- STHO Nasdaq
- Market Cap
- FATE 108.2M
- STHO 117.1M
- IPO Year
- FATE 2013
- STHO N/A
- Fundamental
- Price
- FATE $1.28
- STHO $6.55
- Analyst Decision
- FATE Hold
- STHO
- Analyst Count
- FATE 8
- STHO 0
- Target Price
- FATE $5.43
- STHO N/A
- AVG Volume (30 Days)
- FATE 2.5M
- STHO 131.9K
- Earning Date
- FATE 05-08-2025
- STHO 05-09-2025
- Dividend Yield
- FATE N/A
- STHO N/A
- EPS Growth
- FATE N/A
- STHO N/A
- EPS
- FATE N/A
- STHO N/A
- Revenue
- FATE $13,631,000.00
- STHO $113,297,000.00
- Revenue This Year
- FATE N/A
- STHO N/A
- Revenue Next Year
- FATE N/A
- STHO N/A
- P/E Ratio
- FATE N/A
- STHO N/A
- Revenue Growth
- FATE N/A
- STHO N/A
- 52 Week Low
- FATE $0.66
- STHO $6.09
- 52 Week High
- FATE $5.92
- STHO $14.50
- Technical
- Relative Strength Index (RSI)
- FATE 60.93
- STHO 37.38
- Support Level
- FATE $1.02
- STHO $6.19
- Resistance Level
- FATE $1.49
- STHO $6.85
- Average True Range (ATR)
- FATE 0.17
- STHO 0.40
- MACD
- FATE 0.05
- STHO 0.03
- Stochastic Oscillator
- FATE 74.07
- STHO 30.39
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. It focuses on realizing value for shareholders from the legacy portfolio by maximizing cash flows through active asset management and asset sales.